<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab16">
 <label>Table 26.16</label>
 <caption>
  <p>Drug-induced cases of PML (Bauer et al. 
   <xref ref-type="bibr" rid="CR12">2015</xref>) reproduced with kind permission by Springer Nature
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Medication</th>
    <th>Treatment</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Azathioprine</td>
    <td>Transplantation/autoimmune disease</td>
   </tr>
   <tr>
    <td>Cyclosporine</td>
    <td>Transplantation</td>
   </tr>
   <tr>
    <td>Cyclophosphamide</td>
    <td>Cancer/transplantation/autoimmune disease</td>
   </tr>
   <tr>
    <td>Dimethylfumarate</td>
    <td>Autoimmune disease</td>
   </tr>
   <tr>
    <td>Efalizumab</td>
    <td>Autoimmune disease (psoriasis)</td>
   </tr>
   <tr>
    <td>Fingolimod</td>
    <td>Autoimmune disease</td>
   </tr>
   <tr>
    <td>Infliximab</td>
    <td>Autoimmune disease</td>
   </tr>
   <tr>
    <td>Leflunomid</td>
    <td>Autoimmune disease</td>
   </tr>
   <tr>
    <td>Methotrexate</td>
    <td>Cancer/autoimmune disease</td>
   </tr>
   <tr>
    <td>Mycophenolate</td>
    <td>Transplantation/autoimmune disease</td>
   </tr>
   <tr>
    <td>Natalizumab</td>
    <td>Autoimmune disease</td>
   </tr>
   <tr>
    <td>Rituximab</td>
    <td>Cancer/autoimmune disease</td>
   </tr>
   <tr>
    <td>Tacrolimus</td>
    <td>Transplantation</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
